Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli

被引:72
作者
Mammeri, Hedi [1 ,2 ]
Nordmann, Patrice [2 ]
Berkani, Amira [1 ]
Eb, Francois [1 ]
机构
[1] Univ Amiens, Ctr Hosp, Serv Bacteriol Hygiene, Hop Nord, F-80000 Amiens, France
[2] Univ Paris Sud, AP HP, Hop Bicetre, Fac Med,Serv Bacteriol Virol Hygiene, Paris, K Bicetre, France
关键词
AmpC; porins; carbapenems; beta-lactamase; Escherichia coli;
D O I
10.1111/j.1574-6968.2008.01126.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
ESAC beta-lactamases have increased catalytic efficiencies toward extended-spectrum cephalosporins and to a lesser extent toward imipenem as compared with the wild-type cephalosporinases. We show here that ESAC expression associated with the loss of both OmpC and OmpF porins conferred in Escherichia coli a high level of resistance to ertapenem and reduced the susceptibility to imipenem. On the contrary, ESAC expressed in the OmpC- or OmpF-deficient E. coli strains or narrow-spectrum cephalosporinase expressed in the OmpC-and OmpF-deficient strain do not confer reduced susceptibility to any of the carbapenems. The production of ESAC beta-lactamase in favorable E. coli background may represent an additional mechanism of resistance to ertapenem.
引用
收藏
页码:238 / 240
页数:3
相关论文
共 17 条
[1]  
[Anonymous], [No title captured]
[2]   Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing β-lactamases in Chryseobacterium meningosepticum [J].
Bellais, S ;
Aubert, D ;
Naas, T ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1878-1886
[3]   Analysis of the effects of-42 and-32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC [J].
Caroff, N ;
Espaze, E ;
Gautreau, D ;
Richet, H ;
Reynaud, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) :783-788
[4]  
HANCOCK RE, 1996, J CHEMOTHER, V2, P31
[5]  
Hanson ND, 1999, CURR PHARM DESIGN, V5, P881
[6]   Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C β-lactamase [J].
Kim, JY ;
Jung, HI ;
An, YJ ;
Hun, JH ;
Suh, PG ;
Lee, HS ;
Lee, SH ;
Cha, SS .
MOLECULAR MICROBIOLOGY, 2006, 60 (04) :907-916
[7]  
Lee JH, 2004, MICROB DRUG RESIST, V10, P224, DOI 10.1089/mdr.2004.10.224
[8]   Characterization of blaCMY-10 a novel, plasmid-encoded AmpC-type β-lactamase gene in a clinical isolate of Enterobacter aerogenes [J].
Lee, SH ;
Jeong, SH ;
Park, YM .
JOURNAL OF APPLIED MICROBIOLOGY, 2003, 95 (04) :744-752
[9]   Detection of β-lactamase-mediated resistance [J].
Livermore, DM ;
Brown, DFJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :59-64
[10]   Extension of the hydrolysis spectrum of AmpC β-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix [J].
Mammeri, Hedi ;
Poirel, Laurent ;
Nordmann, Patrice .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (03) :490-494